Water-dispersible protein/polyurethane reaction product |
| OF THE INVENTION In the process of our invention the isocyanate-capped liquid polyurethane ... |
|
Polyurethane hydrogels having enhanced wetting rates |
| What we claim is: 1. A method of improving the wetting rate of a water swellable, lightly ... |
|
Pharmaceutical composition containing bile acid sequestrant enclosed in a size-exclusion membrane |
| OF THE PREFERRED EMBODIMENT In describing the preferred embodiment, certain terminology will be ... |
|
Transparent impact polymers |
| OF THE INVENTION The monomers of the feed mixture of this invention are selected from three ... |
|
Oil reclaimer |
| I claim: 1. An apparatus for removing impurities from lubricating oil, comprising, a container ... |
|
Visual-type hygrometer |
| What is claimed is: 1. The complexes of the alkali metals salts of 3,3',4,4' benzophenone ... |
|
Plant watering indicator |
| I claim: 1. Apparatus for indicating when a plant requires to be watered comprising, a member ... |
|
Affinity detection apparatus |
| In the immunoassay apparatus disclosed herein, the coated member and well have complimentary shapes ... |
|
|
Mutant strain of C. acetobutylicum and process for making butanol
| Details |
Inventors: Jain, Mahendra K.; Beacom, Daniel; Datta, Rathin;
Assignee: Michigan Biotechnology Institute (East Lansing, MI)
Primary Examiner: Naff; David M.
Assistant Examiner: Knode; Marian C.
Attorney, Agent or Firm: Quarles & Brady
A biologically pure asporogenic mutant of Clostridium acetobutylicum is produced by growing sporogenic C. acetobutylicum ATCC 4259 and treating the parent strain with ethane methane sulfonate. The mutant which as been designated C. acetobutylicum ATCC 55025 is useful in an improved ABE fermentation process, and produces high concentrations of butanol and total solvents. |
|
DETAILED DESCRIPTION We claim: 1. A method of producing butanol which comprises anaerobically culturing a biologically pure culture of Clostridium acetobutylicum ATCC 55025 in a nutrient medium with assimilable sources of carbon, nitrogen, and inorganic substances and then recovering the butanol. 2. A biologically pure culture of clostridium acetobutylicum ATCC 55025.
Description:
FIELD OF THE INVENTION The present invention relates to a Novel mutant strain of Clostridium acetobutylicum and a fermentation process for producing butanol using that mutant strain. BACKGROUND OF THE INVENTION Diminishing petroleum resources have made the search for alternative fuel and chemical feedstock sources increasingly important. Butanol, in addition to its many uses as a chemical feedstock, is among the alternatives. The acetone/butanol/ethanol (ABE) fermentation, therefore, has received considerable attention in recent years as a prospective process for production of commodity chemicals from biomass. . sup. 3,6 ABE fermentations are biphasic. During the first (acidogenic) phase logarithmic growth is accompanied by acetic and butyric acid production which also causes a drop in pH. In the second (solventogenic) phase growth ceases and the solvents (ABE) are produced concomitant with consumption of already produced acids and further consumption of the carbohydrates. Hydrogen and carbon dioxide are produced throughout the fermentation. Traditionally, the commercial ABE fermentation was conducted only in a batch mode due to culture instability and spore-forming nature of the organism. Several solvent-yielding fermentation processes using batch or continuous cultures. sup. 2,4,7, chemostats with cell recycling. sup. 1 or immobilized cell systems. sup. 5 have been described. These processes yield butanol, acetone and ethanol in a ratio of 6:3:1. sup. 11. Mixed solvent yields of 29-33% of fermentable carbohydrate have been reported in the literature. . sup. 12 A total solvent concentration of about 16-20 g/L and a butanol concentration of 10-12 g/L is generally the limit due to toxicity of the butanol produced
|
| Related patents |
|
|
Azido-silane compositions
What is claimed is: 1. A solubilized azido-containing silane composition of matter produced by a process which comprises reacting in the presence of a non-aqueous ...
|
|
|
Substituted triazino-benzimidazoles
What we claim is: 1. A triazinobenzimidazole of the formula ##STR36## wherein R.sub.1 is straight-chain or branched alkyl having 1 to 18 carbon atoms; straight-chain or ...
|
|
|
Class of bifunctional additives for bioremediation of hydrocarbon contaminated soils and water
What is claimed is: 1. A method for enhancing microbial degradation of hydrocarbon containing water or soil comprising: contacting the hydrocarbon containing soil or ...
|
|
|
Process for the preparation of halogenomethylketones, in particular of 1,1,1-trifluoroacetone
What is claimes is: 1. Process for the preparation of halogenomethylketones of the formula (I) ##STR4## in which X represents halogen, n represents 1, 2 or 3 and R ...
|
|
|
Antibody-drug conjugates
OF THE INVENTION The present invention pertains to novel immunoconjugates, intermediates thereto, pharmaceutical compositions and methods of use. Throughout the present ...
|
|
|
Monoclonal antibodies against metal chelates
We claim: 1. A monoclonal antibody which exhibits specificity for a complex comprising a chelating agent and a first metallic ion, the antibody having an association ...
|
|
|
Preparation of cyclic carbonates using alkylammonium and tertiary amine catalysts
OF THE INVENTION According to the process of the invention, cyclic carbonates having five or six-membered rings are prepared from the reaction of 1,2- or 1,3-diols and ...
|
|
|
Thrombin inhibitory new dihydroxybenzene ether derivatives
We claim: 1. An ether derivative of a dihydroxybenzene of the formula ##STR40## wherein the ether groups are either ortho- or meta- to one another; A is selected from ...
|
|
|
Deer repellent device and method
What is claimed is: 1. A deer repellent assembly comprising: a 100 foot length of one-quarter inch diameter elongate flexible rope of a cotton and polyester solid braid ...
|
|
|
Solid consumer product compositions containing small particle clyclodextrin complexes
What is claimed is: 1. Pharmaceutical composition comprising an effective amount of active/cyclodextrin inclusion complex with pharmaceutical agent selected from the ...
|
|
|